SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-164443
Filing Date
2023-06-09
Accepted
2023-06-09 16:06:29
Documents
12
Period of Report
2023-06-08
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d457839d8k.htm   iXBRL 8-K 31514
  Complete submission text file 0001193125-23-164443.txt   153160

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA iobt-20230608.xsd EX-101.SCH 2855
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE iobt-20230608_lab.xml EX-101.LAB 17909
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iobt-20230608_pre.xml EX-101.PRE 11237
6 EXTRACTED XBRL INSTANCE DOCUMENT d457839d8k_htm.xml XML 3330
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

IRS No.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41008 | Film No.: 231005271
SIC: 2834 Pharmaceutical Preparations